Blog

Kava is a culturally significant Pacific drink used traditionally with cultural practice as a relaxant, to promote dialog in group settings, to aid in sleep and to manage anxiety. Its anxiolytic and sedative properties may link to the presence of kavalactones which are putative low potency GABA ligands.

The whole Drug Science Team is shocked and incredibly saddened by the news of Hannah Deacon’s passing on May 6th, 2025, after ‘a short and brutal illness’

Stigmatised attitudes, opinions on opioid use, and prior contact with People Who Use Drugs (PWUD) contribute to what policies are publicly supported and implemented to reduce drug-related deaths. This study examined how these variables relate to policy support for the implementation of supervised injection sites, laws protecting bystanders at the scene of an overdose, and over-the-counter naloxone.

We sought to examine nascent trends surrounding the impacts of police drug seizures in the period after a substantial public policy shift surrounding the personal possession of drugs in British Columbia (BC), Canada. We explored the intersection of drug testing and police opioid seizures in Vancouver, BC.

The global regulatory landscape for psilocybin and PSILO-AT remains highly variable, with significant differences in the scope and clarity of medical governance.

Although there is growing support for the protective effects of psychedelics on mental health, recent evidence finds racial and ethnic minorities gain fewer benefits.

The increasing incidence of opioid dependence linked to the consumption of unwashed poppy seeds (UPSs) is an emerging public health concern.

A recent meta-analysis in Drug Science, Policy and Law on the risk associated with the detection of tetrahydrocannabinol (THC) in blood and

On the 26th of February 2025, Clive Bates wrote to an academic at Manchester Metropolitan University, Dr Maxime Boidin, about generating irr

The past 50 years have seen remarkable advances in the science of medicine. The pharmacological treatments of disorders such as hypertension

This paper discusses the topic of safer injecting facilities with those who are likely to use them. Whilst more countries are adopting this

The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4-methylenedioxymethamphetamine (MDMA)

This article discusses the introduction of the safe drug consumption facility in Glasgow and considers some of its potential consequences.

MDMA (now called midomafetamine by the FDA) is a substituted amphetamine first synthesised in 1912 by Merck that has been developed over the

Drug Science and UCL are pleased to announce their collaboration aimed at advancing our understanding of MDMA-assisted psychotherapy.

Since its inception in 2019, T21 has strived to create the largest body of evidence for the safety and efficacy of medical cannabis, providi

MDMA has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies as a novel treatment for PTSD.

To document the prevalence and correlates of suicidal ideation (SI) among individuals seeking cannabis-based medicinal products (CBMPs); to

There are important differences between individuals aged 65+ years and younger individuals receiving cannabis-based medicinal products. Olde

Chronic pain is one of the most common conditions for which people seek treatment with cannabis-based medicinal products (CBMPs) and there i